story of the week
Amrubicin Superior to Topotecan in Small-Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Trial of Amrubicin Versus Topotecan as Second-Line Treatment for Patients With Small-Cell Lung Cancer
J. Clin. Oncol 2014 Nov 10;[EPub Ahead of Print], J von Pawel, R Jotte, DR Spigel, ME O'Brien, MA Socinski, J Mezger, M Steins, L Bosquée, J Bubis, K Nackaerts, JM Trigo, P Clingan, W Schütte, P Lorigan, M Reck, M Domine, FA Shepherd, S Li, MF RenschlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.